Silver Grove Financial Group »

First Tracks Biotherapeutics shares owned by Silver Grove Financial Group

Quarter-by-quarter ownership of First Tracks Biotherapeutics (TRAX) shares owned by Silver Grove Financial Group from 13F filings

Historical chart of Silver Grove Financial Group investment in First Tracks Biotherapeutics

Tip: Access up to 7 years of quarterly data

All positions including First Tracks Biotherapeutics held by Silver Grove Financial Group consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in First Tracks Biotherapeutics by Silver Grove Financial Group

Quarter filed Position value Share count Share price at filing
2026-06-30 $765 38 20.13

More positions owned by Silver Grove Financial Group

Northern Lts Fd Tr Iv Main Sectr Rotn (SECT)
Vanguard Index Fds S&p 500 Etf Shs (VOO)
Ishares Tr Core Us Aggbd Et (AGG)
Advisors Inner Circle Fd Ii 3edge Fixed Etf (EDGF)
NVIDIA Corporation (NVDA)
Apple (AAPL)
Invesco Qqq Tr Unit Ser 1 (QQQ)
Microsoft Corporation (MSFT)
Amazon (AMZN)
Ishares Tr Core S&p500 Etf (IVV)
Alphabet Cap Stk Cl A (GOOGL)
Broadcom (AVGO)
Ishares Tr National Mun Etf (MUB)
Ishares Tr S&p 500 Grwt Etf (IVW)
Vanguard Tax-managed Fds Van Ftse Dev Mkt (VEA)

View all positions for Silver Grove Financial Group

Top funds holding First Tracks Biotherapeutics

EcoR1 Capital
TCG Crossover Management
FMR
Affinity Asset Advisors
BlackRock
Trails Edge Capital Partners
Vanguard Capital Management
Jupiter Topco
Vestal Point Capital
Woodline Partners
Sanofi
683 Capital Management
Adage Capital Partners GP
Balyasny Asset Management
Geode Capital Management

View all funds holding First Tracks Biotherapeutics